Gut microbiota analysis in pediatric-onset multiple sclerosis compared to pediatric monophasic demyelinating

Arlette L Bruijstens1, Sandy Molenaar1, Yu Yi M Wong1

  • 1Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands.

Insights

This study found no significant differences in gut microbiota composition between pediatric multiple sclerosis (MS) patients and controls. However, body mass index (BMI) was associated with gut microbiota variations in children.

Area of Science:

  • Microbiome research
  • Pediatric neurology
  • Immunology

Background:

  • Gut microbiota dysbiosis is implicated in proinflammatory conditions contributing to multiple sclerosis (MS) etiology.
  • Pediatric-onset MS (OMS) offers a unique window into early disease mechanisms due to minimal confounder exposure.
  • Investigating the gut microbiome in pediatric OMS is crucial for understanding disease pathogenesis.

Purpose of the Study:

  • To investigate gut microbiota composition and functional pathways in pediatric-onset MS.
  • To compare gut microbiota between pediatric-onset MS, monophasic acquired demyelinating syndromes (mADS), and healthy controls (HCs).
  • To identify potential microbial biomarkers or alterations associated with early MS development.

Main Methods:

  • Analysis of gut microbiota composition (16S rRNA gene sequencing) and predicted functional pathways (MetaCyc) in pediatric participants (<18 years).
  • Comparison of alpha/beta diversity and individual microbe abundance across pediatric-onset MS, mADS, and HC groups.
  • Statistical testing using nonparametric tests, PERMANOVA, and linear regression to identify significant differences.

Main Results:

  • No significant differences in alpha/beta diversity or microbial functional features were observed between pediatric-onset MS, mADS, and HC groups.
  • Body mass index (BMI) was significantly associated with gut microbiota variations, including lower alpha diversity and altered beta diversity in obese children.
  • Obesity was linked to a higher abundance of specific microbes and functional pathways, independent of MS status.

Conclusions:

  • The study could not validate previous findings on gut microbiota composition and function in pediatric-onset MS using a sensitive 16S rRNA pipeline.
  • Limitations included sample size and the use of disease-modifying therapies (DMTs) in the pediatric MS cohort.
  • Host-related factors, particularly BMI, demonstrated a notable association with gut microbiota variations in the studied pediatric population.
Abstract

Related Concept Videos

Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...